Næste

Automatisk afspilning

MRD’s Potential Role in Treating Acute Myeloid Leukemia

0 Visninger • 07/04/23
Del
Indlejre
administrator
administrator
Abonnenter
0

Harry Erba, MD, PhD; Alexander E. Perl, MD; Eunice Wang, MD; and Jorge E. Cortes, MD, debate the current value of minimal residual disease testing for therapeutic decision-making in acute myeloid leukemia and identify the needs to be addressed before use in standard practice.

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning